Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2023 Filed Mar 14, 2023 20:20 UTC |
De Witte JanDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 26,008 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018446 · doc4.xml · derivative · entry 3 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,033 Underlying: Common Stock · 26,008 shares Expires not disclosed F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:20 UTC |
De Witte JanDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 63,717 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018446 · doc4.xml · derivative · entry 2 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,717 Underlying: Common Stock · 63,717 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:21 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,354 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · derivative · entry 9 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,354 Underlying: Common Stock · 10,354 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:21 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantCommon Stock | 4,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018451 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,147 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:18 UTC |
Singh HarvinderExec VP & PRES, International
|
GrantRestricted Stock Units · Derivative | 3,670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 2 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,635 Underlying: Common Stock · 3,670 shares Expires not disclosed F2 · derivative.exercise_price: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F2 · derivative.exercise_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. F2 · derivative.expiration_date: The award was a restricted stock unit award which will vest 33% on the first and second anniversaries and 34% on the third anniversary of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:18 UTC |
Singh HarvinderExec VP & PRES, International
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,990 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018441 · doc4.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,990 Underlying: Common Stock · 8,990 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:16 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,419 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · derivative · entry 9 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,419 Underlying: Common Stock · 12,419 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:16 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 5,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018435 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,222 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 1,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,177 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 1,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018424 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,921 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC |
Evoli LisaEVP & CHRO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 6,201 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018420 · doc4.xml · derivative · entry 9 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,201 Underlying: Common Stock · 6,201 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:14 UTC |
Evoli LisaEVP & CHRO
|
GrantCommon Stock | 2,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018420 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,137 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantNon-Qualified Stock option (right to buy) · Derivative | 19,912 | $0.00 Strike: $52.87 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · derivative · entry 10 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,912 Underlying: Common Stock · 19,912 shares Expires 2031-03-10 F1 · derivative.exercise_price: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/10/2023. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 8,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,382 Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 20:13 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 9,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018416 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,254 Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:17 UTC |
McBreen Michael J.EVP & President, CSS
|
SaleCommon Stock | 1,843 | $54.29 | $100,064.39 |
DisclosureSEC source: 0001209191-23-017194 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,796 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $54.2931 to $54.3001. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:58 UTC |
McBreen Michael J.EVP & President, CSS
|
Tax withholdingCommon Stock | 723 | $55.09 | $39,830.07 |
DisclosureSEC source: 0001209191-23-016360 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,639 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,566 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · derivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,566 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the stock options vested every first, second, third and fourth anniversaries of the grant date of 03/23/2015. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
SaleCommon Stock | 1,566 | $55.21 | $86,463.09 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,920 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $55.2118 to $55.22. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:20 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
Exercise / conversionCommon Stock | 1,566 | $26.87 | $42,070.59 |
DisclosureSEC source: 0001209191-23-015775 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 21:29 UTC |
Evoli LisaEVP & CHRO
|
SaleCommon Stock | 3,767 | $57.00 | $214,730.68 |
DisclosureSEC source: 0001209191-23-013669 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,605 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $57 to $57.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:35 UTC |
De Witte JanDirector · President & CEO
|
GrantCommon Stock | 8,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009758 · doc4.xml · nonDerivative · entry 1 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,848 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 5,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 4 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,152 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 3 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,511 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 560 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 2 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,111 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:30 UTC |
Schwartz EricEVP, Chief Legal Officer & Sec
|
GrantCommon Stock | 2,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009748 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · EVP, Chief Legal Officer & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,551 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantCommon Stock | 1,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,920 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantCommon Stock | 1,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,037 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantCommon Stock | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,258 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:25 UTC |
DAVIS ROBERT T. JR.EVP & President, TT
|
GrantCommon Stock | 2,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009734 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · EVP & President, TT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,191 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 4 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,362 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 1,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 3 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,443 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 1,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 2 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,763 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:18 UTC |
McBreen Michael J.EVP & President, CSS
|
GrantCommon Stock | 1,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009724 · doc4.xml · nonDerivative · entry 1 McBreen Michael J. · CIK 0001814943 · EVP & President, CSS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,755 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 4 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,089 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 3 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,678 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,293 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:14 UTC |
Mosebrook JeffreySVP, Fin, PFO & PAO
|
GrantCommon Stock | 510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009713 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin, PFO & PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,062 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:07 UTC |
Evoli LisaEVP & CHRO
|
GrantCommon Stock | 1,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 4 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,372 F3 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 11, 2022 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 11, 2023, the first anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:07 UTC |
Evoli LisaEVP & CHRO
|
GrantCommon Stock | 1,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 3 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,235 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:07 UTC |
Evoli LisaEVP & CHRO
|
GrantCommon Stock | 632 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 2 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,181 F2 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 12, 2021 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2023, the second anniversary of the grant date. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:07 UTC |
Evoli LisaEVP & CHRO
|
GrantCommon Stock | 1,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009704 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · EVP & CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,549 F1 · shares: On February 13, 2023, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2022 under the March 13, 2020 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2023, the third anniversary of the grant date. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:17 UTC |
De Witte JanDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 431 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004012 · doc4.xml · derivative · entry 3 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,025 Underlying: Common Stock · 431 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation. F1 · derivative.exercise_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation. F1 · derivative.expiration_date: The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the first installment vested on 1/18/2023 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:17 UTC |
De Witte JanDirector · President & CEO
|
Tax withholdingCommon Stock | 431 | $54.78 | $23,610.18 |
DisclosureSEC source: 0001209191-23-004012 · doc4.xml · nonDerivative · entry 2 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:17 UTC |
De Witte JanDirector · President & CEO
|
Exercise / conversionCommon Stock | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004012 · doc4.xml · nonDerivative · entry 1 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2022 Filed Dec 8, 2022 22:09 UTC |
Mosebrook JeffreySVP, Fin & Princ Acct Officer
|
SaleCommon Stock | 279 | $56.22 | $15,684.32 |
DisclosureSEC source: 0001209191-22-060378 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · SVP, Fin & Princ Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,552 Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:10 UTC |
De Witte JanDirector · President & CEO
|
GrantRestricted Stock Units · Derivative | 29,441 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-055496 · doc4.xml · derivative · entry 1 De Witte Jan · CIK 0001776929 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,456 Underlying: Common Stock · 29,441 shares Expires not disclosed F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 11/1/2022 and which shall be delivered to Mr. De Witte within 30 days of the vesting of each installment. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. Read SEC document |
| October 31, 2022 Filed Jan 31, 2023 21:11 UTC |
ESSIG STUARTDirector
|
GiftCommon Stock | 159,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005679 · doc5.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT III Disclosed balance after: 0 F1 · balance_after: In accordance with the provisions of the Grantor Annuity Trust, 159,012 shares of the Issuer's common stock were transferred from the GRAT to the Stuart M. Essig 2010 Remainder Trust upon termination of the GRAT. Read SEC document |
| October 12, 2022 Filed Oct 13, 2022 20:16 UTC |
Singh HarvinderExec VP & PRES, International
|
GrantRestricted Stock Units · Derivative | 11,965 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053568 · doc4.xml · derivative · entry 1 Singh Harvinder · CIK 0001949782 · Exec VP & PRES, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,965 Underlying: Common Stock · 11,965 shares Expires not disclosed F1 · derivative.exercise_price: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 F1 · derivative.exercise_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 F1 · derivative.expiration_date: The award was a restricted stock unit award which will vest 100% on the third anniversary of the grant date of 10/12/2022 Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:19 UTC |
Evoli LisaExecutive Vice President &CHRO
|
SaleCommon Stock | 1,165 | $55.81 | $65,019.58 |
DisclosureSEC source: 0001209191-22-045420 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Executive Vice President &CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,997 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.